Seven new markers discovered for hard-to-treat breast cancer

October 25, 2013, King's College London
Seven new markers discovered for hard-to-treat breast cancer

(Medical Xpress)—Pioneering research from Breakthrough Breast Cancer scientists has discovered seven molecular markers that contribute to the behaviour of triple negative breast cancers, revealing new insight into this aggressive sub-type of the disease.

By collecting and studying genetic and molecular data from stored tumour samples from more than 110 patients with triple negative breast cancer treated at Guy's and St Thomas' NHS Foundation Trust between 1979 and 2001, the team identified the biological function of these markers, discovering that each played a role in the invasiveness and aggressiveness of triple negative breast cancer tumours.

Led by Professor Andrew Tutt, Director of Breakthrough Breast Cancer's Research Unit at King's College London, the research, published in the journal BMC Genomics, forms part of a large comprehensive study of triple negative .

Professor Andrew Tutt, Director of the Breakthrough Research Unit at King's College London, says: 'We are pleased to have been able to shed more light on this complex group of diseases that we so desperately need to understand better to improve the outlook for our patients.'

This new discovery means scientists now have a better understanding of what causes triple negative breast cancer to develop and spread so quickly. This will help develop targeted drugs which will tackle this hard-to-treat form of the disease as well as helping to predict which patients are most likely to go on to develop .

Dr Matthew Lam, Research Officer at Breakthrough Breast Cancer, says: 'Research into is absolutely crucial and these ground-breaking findings give us more insight into what causes this aggressive subtype to be so difficult to treat and so much more likely to spread.

'This knowledge will help us to develop more personalised treatments for triple negative patients and ultimately save more lives.'

Explore further: Aggressive breast cancers may be sensitive to drugs clogging their waste disposal

More information: www.biomedcentral.com/1471-2164/14/643/abstract

Related Stories

Aggressive breast cancers may be sensitive to drugs clogging their waste disposal

August 12, 2013
In a new paper in Cancer Cell, a team led by Judy Lieberman, PhD, of Boston Children's Hospital's Program in Cellular and Molecular Medicine reports "triple-negative" breast cancers may be vulnerable to drugs that attack ...

Scientists find promising new target for aggressive breast cancer

March 20, 2013
Women with triple-negative breast cancer are more likely to have high levels of the MET biomarker in their tumours, making it a good new target for cancer drugs according to research published in the British Journal of Cancer, ...

Triple-negative breast cancer target for drug development identified

October 3, 2013
Often deadly "triple-negative" breast cancers might be effectively treated in many cases with a drug that targets a previously unknown vulnerability in the tumors, according to a UC San Francisco researcher who described ...

New hope for thousands of women with most aggressive breast cancer

September 7, 2012
(Medical Xpress)—Scientists at The University of Nottingham have identified a protein which could help predict survival outcomes for women with the most aggressive forms of breast cancer.

A form of small pox virus shows potential for treating triple-negative breast cancer

October 1, 2012
Researchers from Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City have shown that a new vaccinia virus, acting as both an oncolytic and anti-angiogenic agent, can enter and kill triple-negative breast cancer ...

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.